SERENA, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.024
AS - Asia 346
EU - Europa 334
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.708
Nazione #
US - Stati Uniti d'America 3.022
CN - Cina 305
FI - Finlandia 99
DE - Germania 76
IT - Italia 50
SE - Svezia 47
VN - Vietnam 23
GB - Regno Unito 19
IN - India 11
UA - Ucraina 10
IE - Irlanda 8
RU - Federazione Russa 7
NL - Olanda 6
FR - Francia 3
IL - Israele 3
BE - Belgio 2
CA - Canada 2
NO - Norvegia 2
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
KR - Corea 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SG - Singapore 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 3.708
Città #
Woodbridge 419
Chandler 387
Fairfield 367
Houston 241
Ann Arbor 209
Wilmington 167
Cambridge 154
Ashburn 137
Seattle 137
Princeton 74
Beijing 73
Des Moines 64
Nanjing 64
Jacksonville 62
Medford 53
Helsinki 43
San Diego 42
Boardman 35
New York 32
Jinan 26
Roxbury 26
Dong Ket 23
Padova 22
Shenyang 16
Guangzhou 14
Hebei 14
Nanchang 11
Changsha 10
Dearborn 10
Tianjin 10
Dublin 8
Falls Church 7
Jiaxing 6
Norwalk 6
Nürnberg 6
Redwood City 6
Zhengzhou 6
Munich 5
Pune 5
Haikou 4
Ningbo 4
Hangzhou 3
Hefei 3
Indiana 3
Kunming 3
Lanzhou 3
Milan 3
Shanghai 3
Venezia 3
Amsterdam 2
Bologna 2
Brussels 2
Fuzhou 2
Hackney 2
Hounslow 2
Leawood 2
London 2
Miami 2
Oslo 2
Redmond 2
Rockville 2
Taizhou 2
Torino 2
Vicenza 2
Acton 1
Alghero 1
Atlanta 1
Barcelos 1
Belgrade 1
Bengaluru 1
Birmingham 1
Borås 1
Brunswick 1
Chicago 1
Chiswick 1
Costa Mesa 1
Crossville 1
Dallas 1
Ferrara 1
Frankfurt am Main 1
Istanbul 1
Los Angeles 1
Manila 1
Muizenberg 1
Murfreesboro 1
Newcastle 1
Nuremberg 1
Orlando 1
Paris 1
Pinehaven 1
Prague 1
Prescot 1
Rome 1
Saint-Jude 1
Secaucus 1
Shaoxing 1
Singapore 1
Stockholm 1
Taiyuan 1
Tappahannock 1
Totale 3.095
Nome #
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle 119
Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells 111
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 110
Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate 105
High-efficiency cellular reprogramming with microfluidics 105
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 101
Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for in vitro Functional Assay 99
Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli 99
Enhancement of viability of muscle precursor cells on 3D scaffold in a perfusion bioreactor 96
Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate 92
Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold 88
Microfluidic-assisted cyclic mechanical stimulation affects cellular membrane integrity in a human muscular dystrophy in vitro model 86
Electrical stimulation of human embryonic stem cells: Cardiac differentiation and the generation of reactive oxygen species. 84
Microfluidic-assisted cyclic mechanical stimulation affects cellular membrane integrity in a human muscular dystrophy in vitro model 83
Human-on-chip for therapy development and fundamental science 81
Soft substrates drive optimal differentiation of human healthy and dystrophic myotubes 81
Analysis of calcium transients and uniaxial contraction force in single human embryonic stem cell-derived cardiomyocytes on microstructured elastic substrate with spatially controlled surface chemistries 74
Controlled cardiac differentiation of human embryonic stem cell-derived embryoid bodies in scalable bioreactors 72
Single-cell PCR analysis of murine embryonic stem cells cultured on different substrates highlights heterogeneous expression of stem cell markers 72
Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance 71
A microfluidic platform for the spatial-temporal generation of infarcted heart conditions: highthroughput screening on human Embryonic Stem Cells-derived cardiomyocytes 70
Culture of satellite cells in an electrically-stimulated three-dimensional scaffold for the generation of skeletal muscle engineered graft 70
Single-cell PCR analysis of murine embryonic stem cells cultured on different substrates highlights heterogeneous expression of stem cell markers 70
Reversible alteration of calcium dynamics in cardiomyocytes during acute hypoxia transient in a microfluidic platform. 68
Microtechnology for stem cell culture 66
Skeletal muscle differentiation on a chip shows human donor mesoangioblasts’ efficiency in restoring dystrophin in a duchenne muscular dystrophy model 63
Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne Muscular Dystrophy patient-derived cardiomyocytes. 62
An in vitro model for cardiac cell therapy: coupling a microfluidic platform with arrayed human embryonic stem cells-derived cardiomyocytes for screening pathological conditions 61
Culture of Human Embryonic Stem Cell-derived Embryoid Bodies in multiscale bioreactors for optimal control of cardiac differentiation 59
ENGINEERING A 3D IN VITRO MODEL OF HUMAN SKELETAL MUSCLE 58
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 56
Dystrophin expression restoration by human artificial chromosome in cardiomyocytes-derived from DMD patient hiPS cells 53
Microfluidic-driven processes enhance control and optimization of adenoviral infection efficiency on cell cultures 51
Microscale in vitro model for screening pathological conditions on human embryonic stem cell-derived cardiomyocytes 51
Muscle tissue micro engineering 51
Substrate-driven maturation of human pluripotent stem cell-derived cardiomyocytes 48
Effects of electrical stimulation on ROS expression of human embryonic stem cell 48
Alteration of calcium dynamics in murine cardiomyocytes during acute hypoxia 48
An in vitro model for cardiac cell therapy: coupling a microfluidic platform with arrayedhuman embryonic stem cells-derived cardiomyocytes for screening pathological conditions 47
A microfluidic platform for the spatial-temporal generation of infarcted heart conditions: highthroughput screening on human Embryonic Stem Cells-derived cardiomyocytes 47
Cyclic mechanical stretch affects membrane integrity during myogenesis 46
Mesoangioblasts contribution to dystrophin restoration in a human in vitro model 45
Microscale in vitro technologies for screening pathological conditions on human embryonic stem cells-derived cardiomyocytes: an in vitro model for cardiac cell therapy 45
Highthroughput microfluidic platform to enhance adenoviral vector-mediated transgene expression 45
hESC-CM maturation is driven by the cell-substrate interaction 44
Dystrophin restoration in mdx mice transplanted with wt satellite cells 43
Controlled cardiac differentiation of human embryonic stem cell-derived embryoid bodies in scalable bioreactors 38
Microscale Tissue Engineering of human skeletal and cardiac muscles for in vitro applications 36
Culture of satellite cells in electrical stimulated 3D collagen scaffold for the creation of skeletal-muscle engineered graft 35
Production of arrays of cardiac organoids and skeletal muscle fibers by micropatterning techniques 33
One-step high-throughput reprogramming and differentiation on a chip 32
Micropatterning topology on soft substrates affects myoblasts proliferation and differentiation 32
Microfluidic cell-stretching device for mechano-transduction studies 30
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 29
In vitro engineering of muscle precursor cell niche by mimicking multiple stimuli 28
Complete genetic correction of cardiomyocytes from dystrophic patient-derived human induced pluripotent stem cells 27
Engineering the cell culture microenvironment for in vitro model development 26
Engineering microfluidic-technologies for culturing human embryonic stem cells 25
One-step high-throughput reprogramming and differentiation on a chip 24
Microenvironment design for the development of an in vitro model of Human Duchenne Muscular Dystrophy 23
Engineering microfluidics for mimicking stem cells microenvironment 21
The role of mechanotransduction in human pluripotent stem cell derived-cardiomyocytes 21
MYOD modified mRNA drives direct on-chip programming of human pluripotent stem cells into skeletal myocytes 21
Totale 3.725
Categoria #
all - tutte 9.997
article - articoli 5.937
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 195
Totale 16.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019263 0 0 0 0 0 1 3 15 2 57 101 84
2019/2020732 130 19 2 43 70 47 61 74 70 151 46 19
2020/2021371 14 28 8 43 22 19 24 23 53 46 47 44
2021/2022599 13 120 59 34 20 35 30 62 25 8 42 151
2022/2023812 114 94 10 102 113 135 2 65 112 12 41 12
2023/2024235 10 50 51 39 36 49 0 0 0 0 0 0
Totale 3.725